Back to News
Market Impact: 0.2
Wall Street Analysts Believe Globus Medical (GMED) Could Rally 25.03%: Here's is How to Trade
Source: zacks.com
Analyst EstimatesAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
Analysts’ average price target for Globus Medical (GMED) implies ~25% upside from current levels. The article notes that price-target accuracy has been mixed historically, but it highlights strong analyst agreement and upward revisions to earnings estimates as the key supportive signal. Net: modestly positive sentiment that could support the stock, though likely not a major market-moving catalyst.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
GMED0.35
More News
- ‘If nothing is done, it’s almost inevitable’: Ukraine’s Yuriy Ryzhenkov on why steelmaking is on the brink of collapse as Russian bombing intensifies
- Why is LG Innotek stock plunging today?
- RBI Tightens Rupee Defense as Pricey Crude, Foreign Outflows Bite: USD/INR
- TotalEnergies, KKR expand U.S. solar venture with 700 MW addition
- TSMC expected to report sixth straight quarter of record profit thanks to AI boom
- Vår Energi cuts 2026 output forecast; Q3 production at 369,000 boepd